BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22999801)

  • 1. Flaviviruses and their antigenic structure.
    Heinz FX; Stiasny K
    J Clin Virol; 2012 Dec; 55(4):289-95. PubMed ID: 22999801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flaviviruses and flavivirus vaccines.
    Heinz FX; Stiasny K
    Vaccine; 2012 Jun; 30(29):4301-6. PubMed ID: 22682286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis.
    Lai CJ; Monath TP
    Adv Virus Res; 2003; 61():469-509. PubMed ID: 14714441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of previous heterologous flavivirus vaccinations on human antibody responses in tick-borne encephalitis and dengue virus infections.
    Roßbacher L; Malafa S; Huber K; Thaler M; Aberle SW; Aberle JH; Heinz FX; Stiasny K
    J Med Virol; 2023 Nov; 95(11):e29245. PubMed ID: 38009693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formalin-inactivated whole virus and recombinant subunit flavivirus vaccines.
    Eckels KH; Putnak R
    Adv Virus Res; 2003; 61():395-418. PubMed ID: 14714438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with Immune Complexes Modulates the Fine Specificity of Antibody Responses to a Flavivirus Antigen.
    Tsouchnikas G; Zlatkovic J; Jarmer J; Strauß J; Vratskikh O; Kundi M; Stiasny K; Heinz FX
    J Virol; 2015 Aug; 89(15):7970-8. PubMed ID: 26018152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human antibody response to immunization with 17D yellow fever and inactivated TBE vaccine.
    Kayser M; Klein H; Paasch I; Pilaski J; Blenk H; Heeg K
    J Med Virol; 1985 Sep; 17(1):35-45. PubMed ID: 2995571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization.
    Chávez JH; Silva JR; Amarilla AA; Moraes Figueiredo LT
    Biologicals; 2010 Nov; 38(6):613-8. PubMed ID: 20817489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dengue and other emerging flaviviruses.
    Solomon T; Mallewa M
    J Infect; 2001 Feb; 42(2):104-15. PubMed ID: 11531316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic classification and taxonomy of flaviviruses (family Flaviviridae) emphasizing a universal system for the taxonomy of viruses causing tick-borne encephalitis.
    Calisher CH
    Acta Virol; 1988 Sep; 32(5):469-78. PubMed ID: 2904743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis.
    Holzmann H; Kundi M; Stiasny K; Clement J; McKenna P; Kunz C; Heinz FX
    J Med Virol; 1996 Jan; 48(1):102-7. PubMed ID: 8825718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in flavivirus vaccine development.
    Coller BA; Clements DE; Martyak T; Yelmene M; Thorne M; Parks DE
    IDrugs; 2010 Dec; 13(12):880-4. PubMed ID: 21154147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available.
    Ishikawa T; Yamanaka A; Konishi E
    Vaccine; 2014 Mar; 32(12):1326-37. PubMed ID: 24486372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines Against Dengue and West Nile Viruses in India: The Need of the Hour.
    Gore MM
    Viral Immunol; 2020; 33(6):423-433. PubMed ID: 32320353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research advances in plant-made flavivirus antigens.
    Martínez CA; Giulietti AM; Talou JR
    Biotechnol Adv; 2012; 30(6):1493-505. PubMed ID: 22480936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design.
    Rey FA; Stiasny K; Vaney MC; Dellarole M; Heinz FX
    EMBO Rep; 2018 Feb; 19(2):206-224. PubMed ID: 29282215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Many Faces of a Dynamic Virion: Implications of Viral Breathing on Flavivirus Biology and Immunogenicity.
    Dowd KA; Pierson TC
    Annu Rev Virol; 2018 Sep; 5(1):185-207. PubMed ID: 30265634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccination.
    Bradt V; Malafa S; von Braun A; Jarmer J; Tsouchnikas G; Medits I; Wanke K; Karrer U; Stiasny K; Heinz FX
    NPJ Vaccines; 2019; 4():38. PubMed ID: 31508246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.
    Guy B; Guirakhoo F; Barban V; Higgs S; Monath TP; Lang J
    Vaccine; 2010 Jan; 28(3):632-49. PubMed ID: 19808029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.